Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Developing a Natural History Model for Duchenne Muscular Dystrophy.

PharmacoEconomics - open·2024
Same author

Developing a Natural History Model for Duchenne Muscular Dystrophy.

PharmacoEconomics - open·2023
Same author

Nitrite activation of nitrate reductase in higher plants.

Planta·2014
Same author

Incidence of diabetes mellitus in a population-based cohort of persons with chronic hepatitis B virus infection.

Journal of viral hepatitis·2013
Same author

Diabetes among Alaska Natives: a review.

International journal of circumpolar health·2004
Same author

[Cardiomyopathy associated with uncontrolled self medication of anabolic steroids].

Zeitschrift fur Kardiologie·2002

Related Experiment Video

Updated: Jul 17, 2026

BEST: Barcode Enabled Sequencing of Tetrads
12:59

BEST: Barcode Enabled Sequencing of Tetrads

Published on: May 1, 2014

The Alaska Native diabetes program.

C D Schraer1, A M Mayer, A M Vogt

  • 1Alaska Native Medical Center Diabetes Program, Anchorage 99508, USA. cdschraer@anthc.org

International Journal of Circumpolar Health
|January 5, 2002
PubMed
Summary

Diabetes care for Alaska Natives shows positive outcomes despite challenges. The program effectively manages diabetes and its complications, with care levels comparable to urban clinics, though primary prevention remains a hurdle.

More Related Videos

Human Pseudoislet System for Synchronous Assessment of Fluorescent Biosensor Dynamics and Hormone Secretory Profiles
08:04

Human Pseudoislet System for Synchronous Assessment of Fluorescent Biosensor Dynamics and Hormone Secretory Profiles

Published on: November 3, 2023

Isolated Pancreatic Islet Treatment and Apoptosis Measurement
09:36

Isolated Pancreatic Islet Treatment and Apoptosis Measurement

Published on: May 2, 2025

Related Experiment Videos

Last Updated: Jul 17, 2026

BEST: Barcode Enabled Sequencing of Tetrads
12:59

BEST: Barcode Enabled Sequencing of Tetrads

Published on: May 1, 2014

Human Pseudoislet System for Synchronous Assessment of Fluorescent Biosensor Dynamics and Hormone Secretory Profiles
08:04

Human Pseudoislet System for Synchronous Assessment of Fluorescent Biosensor Dynamics and Hormone Secretory Profiles

Published on: November 3, 2023

Isolated Pancreatic Islet Treatment and Apoptosis Measurement
09:36

Isolated Pancreatic Islet Treatment and Apoptosis Measurement

Published on: May 2, 2025

Area of Science:

  • Public Health
  • Epidemiology
  • Indigenous Health

Background:

  • Diabetes care for indigenous populations presents unique logistical challenges.
  • Alaska Natives with diabetes often lack direct access to physicians and hospitals.
  • Tribal management of healthcare delivery is crucial for remote populations.

Purpose of the Study:

  • To describe a diabetes care program for indigenous people in Alaska.
  • To present data on the epidemiology of diabetes and its complications.
  • To highlight program successes and challenges in optimizing health outcomes.

Main Methods:

  • Descriptive epidemiology using yearly chart review data.
  • Population-based registry for monitoring and follow-up.
  • Audits of care against national guidelines for quality assessment.

Main Results:

  • Diabetes prevalence among Alaska Natives increased by 80% from 1985 to 1998.
  • Incidence rates for lower extremity amputation and end-stage renal disease were 6.1/1000 and 2.0/1000, respectively.
  • Care quality for Alaska Natives with diabetes is comparable to that in urban Alaskan clinics.

Conclusions:

  • Diabetes care for Alaska Natives is effective, despite challenges.
  • Complication rates are comparable to or lower than national averages.
  • Program elements can inform chronic disease management in other isolated indigenous communities.